However, for individuals actively managing complex, reactive chronic illnesses like Long COVID, ME/CFS, or severe dysautonomia, such high starting doses are rarely recommended due to the high potential for gastrointestinal upset or rapid, uncomfortable detoxification reactions (often referred to as a Herxheimer reaction)
Here are the steps you should follow if you suspect a problem: Contact Your Healthcare Provider: If you have any concerns about the medications safety, reach out to your healthcare provider for guidance
Dysbiosis is common among conditions like AD, PD, MS, MDD, BD, anxiety, PTSD, and stroke
Micronucleus testing revealed no clastogenic effects, indicating the peptide does not damage chromosomes
The BPC-157 dose warrants specific context: 500mcg (0.5mg) per serving is the disclosed oral dose